Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Barrick Gold, Amarin, and California Resources Jumped Today

By Dan Caplinger - Sep 24, 2018 at 4:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Find out which of these stocks gained the most.

The stock market came into the new week on a negative note, with the Dow Jones Industrial Average seeing the biggest declines among the major benchmarks. Renewed trade fears and political concerns out of Washington seemed to worry investors, and some trepidation about the speed with which interest rates have risen in recent days also weighed on some portions of the market. Yet some individual companies had good news that sent their shares higher despite the downbeat mood generally. Barrick Gold ( GOLD -2.47% ), Amarin ( AMRN -1.94% ), and California Resources ( CRC ) were among the best performers on the day. Here's why they did so well.

Barrick makes a buy

Shares of Barrick Gold climbed 5% after the company announced a huge acquisition that will create an even bigger player in the gold mining space. Barrick will acquire Randgold Resources in a deal that will pay Randgold shareholders 6.128 shares of Barrick for every Randgold share they own. Following the deal, Barrick shareholders will own almost exactly two-thirds of the combined company, with Randgold shareholders getting the remaining third. The merged company will be the largest gold-mining specialist in the world, and Barrick CEO John Thornton believes that it "will create a new champion for value creation in the gold mining industry."

Large gold bar with Barrick imprint.

Image source: Barrick Gold.

Amarin flies high on trial results

Amarin stock soared a whopping 316% in the wake of favorable clinical trial results for the company's prescription fish oil cardiovascular treatment. The biopharmaceutical specialist said that Vascepa successfully demonstrated roughly a 25% relative risk reduction in first occurrences of major adverse cardiovascular events, including death, stroke, and other indications. Vascepa also had favorable safety characteristics in the study. Having proved its naysayers wrong about whether a fish oil product could be effective, Amarin hopes to see a major expansion in revenue from Vascepa going forward.

Soaring oil lifts California Resources

Finally, shares of California Resources gained 18%. Monday was a strong day for the energy market overall, as global crude oil prices topped the $80-per-barrel mark. Domestically, crude prices are lower, in part because domestic producers still face challenges in getting their products from hard-to-reach fields to transportation hubs and refineries. With California Resources in particular remaining more highly leveraged than many of its peers, it makes sense that the stock is among the leading gainers across the oil and gas industry today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Amarin Corporation plc Stock Quote
Amarin Corporation plc
$3.54 (-1.94%) $0.07
Barrick Gold Corporation Stock Quote
Barrick Gold Corporation
$18.14 (-2.47%) $0.46
California Resources Corporation Stock Quote
California Resources Corporation

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/09/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.